AML-103 Clinical Outcomes of Patients With High-Risk Acute Promyelocytic Leukemia (APL) Treated With All-Trans Retinoic Acid (ATRA)/Arsenic Trioxide (ATO)–Based Induction and Consolidation Without Maintenance Therapy: A Single-Institution Study

Patients with high-risk APL have a worse event-free survival than low-risk APL patients. Maintenance therapy improves disease-free survival in high-risk APL patients treated with ATRA plus chemotherapy as induction and consolidation therapy. The role of maintenance therapy in patients treated with a...

Full description

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 23; p. S269
Main Authors Yohannan, Binoy, Sharma, Akanksha, Sridhar, Arthi, Cervoni-Curet, Frances, Rios, Adan
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2023
Subjects
AML
ATO
ATRA
high-risk APL
AML
high-risk APL
ATRA
ATO
case
Online AccessGet full text
ISSN2152-2650
2152-2669
DOI10.1016/S2152-2650(23)00995-3

Cover